Numerai’s PetMed Express PETS Stock Holding History

Numerai’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,033	Closed	-$216K	–	295
2023 Q3	$216K	Buy	+21,033	New	+$260K	0.07%	200

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Numerai's PETS Position: Q4 2023 in Review

Numerai sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 21,033 shares — an estimated $216K sold.

Numerai first reported a position in PETS in Q3 2023 and held it in 1 quarter. The position peaked at $216K in Q3 2023. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

Numerai reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
Numerai sold 21,033 PetMed Express shares in Q4 2023, an estimated $216K.
Numerai first reported a position in PetMed Express in Q3 2023 and held it in 1 quarter.
Numerai's PetMed Express position peaked at $216K in Q3 2023.
130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Numerai's 13F filing for Q4 2023, filed 14 Feb 2024.